Quebec nurse had to clean up after husband's death in Montreal hospital
On a night she should have been mourning, a nurse from Quebec's Laurentians region says she was forced to clean up her husband after he died at a hospital in Montreal.
Eight years ago, a team of researchers launched a project to carefully repeat early but influential lab experiments in cancer research.
They recreated 50 experiments, the type of preliminary research with mice and test tubes that sets the stage for new cancer drugs. The results reported Tuesday: About half the scientific claims didn't hold up.
"The truth is we fool ourselves. Most of what we claim is novel or significant is no such thing," said Dr. Vinay Prasad, a cancer doctor and researcher at the University of California, San Francisco, who was not involved in the project.
It's a pillar of science that the strongest findings come from experiments that can be repeated with similar results.
In reality, there's little incentive for researchers to share methods and data so others can verify the work, said Marcia McNutt, president of the National Academy of Sciences. Researchers lose prestige if their results don't hold up to scrutiny, she said.
And there are built-in rewards for publishing discoveries.
But for cancer patients, it can raise false hopes to read headlines of a mouse study that seems to promise a cure "just around the corner," Prasad said. "Progress in cancer is always slower than we hope."
The new study reflects on shortcomings early in the scientific process, not with established treatments. By the time cancer drugs reach the market, they've been tested rigorously in large numbers of people to make sure they are safe and they work.
For the project, the researchers tried to repeat experiments from cancer biology papers published from 2010 to 2012 in major journals such as Cell, Science and Nature.
Overall, 54% of the original findings failed to measure up to statistical criteria set ahead of time by the Reproducibility Project, according to the team's study published online Tuesday by eLife. The nonprofit eLife receives funding from the Howard Hughes Medical Institute, which also supports The Associated Press Health and Science Department.
Among the studies that did not hold up was one that found a certain gut bacteria was tied to colon cancer in humans. Another was for a type of drug that shrunk breast tumors in mice. A third was a mouse study of a potential prostate cancer drug.
A co-author of the prostate cancer study said the research done at Sanford Burnham Prebys research institute has held up to other scrutiny.
"There's plenty of reproduction in the (scientific) literature of our results," said Erkki Ruoslahti, who started a company now running human trials on the same compound for metastatic pancreatic cancer.
This is the second major analysis by the Reproducibility Project. In 2015, they found similar problems when they tried to repeat experiments in psychology.
Study co-author Brian Nosek of the Center for Open Science said it can be wasteful to plow ahead without first doing the work to repeat findings.
"We start a clinical trial, or we spin up a startup company, or we trumpet to the world `We have a solution,' before we've done the follow-on work to verify it," Nosek said.
The researchers tried to minimize differences in how the cancer experiments were conducted. Often, they couldn't get help from the scientists who did the original work when they had questions about which strain of mice to use or where to find specially engineered tumor cells.
"I wasn't surprised, but it is concerning that about a third of scientists were not helpful, and, in some cases, were beyond not helpful," said Michael Lauer, deputy director of extramural research at the National Institutes of Health.
NIH will try to improve data sharing among scientists by requiring it of grant-funded institutions in 2023, Lauer said.
"Science, when it's done right, can yield amazing things," Lauer said.
For now, skepticism is the right approach, said Dr. Glenn Begley, a biotechnology consultant and former head of cancer research at drugmaker Amgen. A decade ago, he and other in-house scientists at Amgen reported even lower rates of confirmation when they tried to repeat published cancer experiments.
Cancer research is difficult, Begley said, and "it is very easy for researchers to be attracted to results that look exciting and provocative, results that appear to further support their favorite idea as to how cancer should work, but that are just wrong."
------
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.
On a night she should have been mourning, a nurse from Quebec's Laurentians region says she was forced to clean up her husband after he died at a hospital in Montreal.
Cuba's foreign affairs minister has apologized to a Montreal-area family after they were sent the wrong body following the death of a loved one.
The federal government's proposed change to capital gains taxation is expected to increase taxes on investments and mainly affect wealthy Canadians and businesses. Here's what you need to know about the move.
Prime Minister Justin Trudeau is accusing Conservative Leader Pierre Poilievre of welcoming 'the support of conspiracy theorists and extremists,' after the Conservative leader was photographed meeting with protesters, which his office has defended.
A North Bay, Ont., lawyer who abandoned 15 clients – many of them child protection cases – has lost his licence to practise law.
A Toronto couple are speaking out about their 'extremely dangerous' experience on board a sinking tour boat in the Dominican Republic last week.
Boeing said Wednesday that it lost US$355 million on falling revenue in the first quarter, another sign of the crisis gripping the aircraft manufacturer as it faces increasing scrutiny over the safety of its planes and accusations of shoddy work from a growing number of whistleblowers.
Members of the Bank of Canada's governing council were split on how long the central bank should wait before it starts cutting interest rates when they met earlier this month.
It's no secret that spring can be a tumultuous time for Canadian weather, and as an unseasonably mild El Nino winter gives way to summer, there's bound to be a few swings in temperature that seem out of the ordinary. From Ontario to the Atlantic, though, this week is about to feel a little erratic.
A property tax bill is perplexing a small townhouse community in Fergus, Ont.
When identical twin sisters Kim and Michelle Krezonoski were invited to compete against some of the world’s most elite female runners at last week’s Boston Marathon, they were in disbelief.
The giant stone statues guarding the Lions Gate Bridge have been dressed in custom Vancouver Canucks jerseys as the NHL playoffs get underway.
A local Oilers fan is hoping to see his team cut through the postseason, so he can cut his hair.
A family from Laval, Que. is looking for answers... and their father's body. He died on vacation in Cuba and authorities sent someone else's body back to Canada.
A former educational assistant is calling attention to the rising violence in Alberta's classrooms.
The federal government says its plan to increase taxes on capital gains is aimed at wealthy Canadians to achieve “tax fairness.”
At 6'8" and 350 pounds, there is nothing typical about UBC offensive lineman Giovanni Manu, who was born in Tonga and went to high school in Pitt Meadows.
Kevin the cat has been reunited with his family after enduring a harrowing three-day ordeal while lost at Toronto Pearson International Airport earlier this week.